Tag Archives: Abilify

Featured Stories
Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Lawsuits Allege Abilify Caused Impulse-Control Problems

Lawsuits Allege Abilify Caused Impulse-Control Problems

Abilify Lawsuits Allege Gambling Addiction, Compulsive Behaviors Bristol-Myers Squibb and Otsuka Pharmaceuticals are facing lawsuits alleging that the antipsychotic medication Abilify caused impulse-control problems, including pathological gambling. Litigation continues to mount as cases are consolidated into a federal multidistrict litigation … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Abilify Compulsive Behavior Lawsuits to be Consolidated in MDL

Abilify Compulsive Behavior Suits to be Consolidated in MDL

A federal multidistrict litigation (MDL) has been established for lawsuits alleging that the antipsychotic drug Abilify caused compulsive behaviors, such as gambling. Plaintiffs allege that drug makers Otsuka Pharmaceuticals and Bristol-Myers Squibb knew about these risks but failed to inform … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

FDA Updates Abilify Label to Include Compulsive Behaviors

FDA Updates Abilify Label to Include Compulsive Behaviors

The U.S. Food and Drug Administration (FDA) has updated the warning label on Abilify, Abilify Maintena, Aristada and generic aripiprazole to include information about compulsive behavior. According to the safety announcement, there have been reports of uncontrollable urges to gamble, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.